GILD price target
Gilead Sciences, Inc. · end-of-day data as of Oct 16, 2026
Gilead Sciences, Inc.
$156.19+21.5%
Buy · 28 analystsPT $159.20 +1.9%
The average price target of the 20 analyst firms that published one in the last 12 months is $159.20 for GILD, 1.9% above the last close of $156.19 on Oct 16, 2026. Targets range from $126.28 to $178.77, with a median of $163.19. Rating consensus: Buy.
Summary
- Target upside+1.9%
- ConsensusBuy
Analyst price targets
Low$126.28
Average$159.20
Median$163.19
High$178.77
Upside+1.9%
20 firms with a target in the last 12 months · last close $156.19 · as of Oct 16, 2026
Morgan Stanley$1472026-01-13
UBS$1462026-01-07
Bernstein$1332025-12-29
Wolfe Research$1472025-12-15
Morgan Stanley$1442025-12-12
HSBC$1322025-12-10
+5 more
RBC Capital$1042025-10-31
Jefferies$1792026-03-10
Barclays$1522026-02-19
Mizuho Securities$1652026-02-19
UBS$1692026-02-18
BMO Capital$1662026-02-11
Bernstein$1582026-02-11
+12 more
Maxim Group$1632026-05-20
Morgan Stanley$1662026-05-10
Truist Financial$1542026-05-08
Morgan Stanley$1712026-04-10
Truist Financial$1532026-04-08
RBC Capital$1192026-08-05
Truist Financial$1482026-08-05
Barclays$1422026-07-29
Leerink Partners$1262026-07-20
RBC Capital$1262026-07-07
RBC Capital$1182026-06-01
Morgan Stanley$1632026-07-27
Morgan Stanley$1642026-07-08
HSBC$1522026-07-06
Raymond James$1632026-10-12
Truist Financial$1572026-10-07
HSBC$1732026-09-10
RBC Capital$1272026-10-08
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets
Strong buy 6 · Buy 16 · Hold 5 · Sell 0 · Strong sell 1